Examinando por Autor "Castillo Lira, Betsy Julie"

Seleccione resultados tecleando las primeras letras
Mostrando 1 - 1 de 1
  • Miniatura
    ÍtemAcceso abierto
    Critical review: effect of micronutrient supplementation and its influence on symptomatic complications in the patient with diabetic nephropathy
    (Universidad Privada Norbert Wiener, 2021-12-22) Castillo Lira, Betsy Julie; León Cáceres, Johanna del Carmen
    Diabetic nephropathy is a disease that alters the microcirculation with functional and structural alterations, such as inflammatory and degenerative processes related to hyperglycemia, which are linked to aggravating factors. In diabetic patients, 20 to 40% have diabetic nephropathy, making it the leading cause of morbidity and mortality. This secondary research, titled 'Critical Review: Effect of Micronutrient Supplementation and Its Influence on Symptomatic Complications in Diabetic Nephropathy Patients,' aimed to identify the effect of micronutrient supplementation and its influence on symptomatic complications in diabetic nephropathy patients. The clinical question was: 'What are the effects of micronutrient supplementation and its influence on symptomatic complications in diabetic nephropathy patients?' The methodology used was Evidence-Based Nutrition (NuBE). Information was searched through Google Scholar, Scielo, PubMed, Redalic, and Scopus, finding 28 articles, with 14 selected and evaluated using the critical reading tool CASPE. The article titled 'Oral Magnesium Supplementation Improved Lipid Profile but Increased Insulin Resistance in Diabetic Nephropathy Patients: A Double-Blind Randomized Controlled Trial' was selected, which has an evidence level of AI and a strong recommendation grade. The critical commentary concluded that magnesium supplementation in diabetic nephropathy patients had an unfavorable effect on insulin sensitivity but also observed a favorable effect in reducing microalbuminuria. Based on the study findings, magnesium supplementation is recommended in diabetic nephropathy patients at a prolonged and adjusted dosage for future studies.